Granules India is currently trading at Rs. 146.80, up by 7.15 points or 5.12% from its previous closing of Rs. 139.65 on the BSE.
The scrip opened at Rs. 142.45 and has touched a high and low of Rs. 148.40 and Rs. 142.00 respectively. So far 97312 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 152.70 on 21-Jan-2020 and a 52 week low of Rs. 83.70 on 04-Feb-2019.
Last one week high and low of the scrip stood at Rs. 152.70 and Rs. 131.05 respectively. The current market cap of the company is Rs. 3743.80 crore.
The promoters holding in the company stood at 42.90%, while Institutions and Non-Institutions held 20.95% and 36.14% respectively.
Granules India has reported over 2-fold jump in its net profit at Rs 88.47 crore for the quarter third quarter ended December 31, 2019 as compared to Rs 40.09 crore for the same quarter in the previous year. Total income of the company increased by 5.72% at Rs 620.18 crore for Q3FY20 as compared Rs 586.65 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 6.15% in its net profit at Rs 64.03 crore for the quarter under review as compared to Rs 60.32 crore for the same quarter in the previous year. Total income of the company increased by 10.95% at Rs 707.47 crore for Q3FY20 as compared Rs 637.65 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1507.00 |
Dr. Reddys Lab | 5988.55 |
Cipla | 1397.90 |
Zydus Lifesciences | 929.90 |
Lupin | 1592.20 |
View more.. |